154 related articles for article (PubMed ID: 28267544)
1. First ultrasound diagnosis of BI-RADS 3 lesions in young patients: Can 6-months follow-up be sufficient to assess stability?
Marcon M; Frauenfelder T; Becker AS; Dedes KJ; Boss A
Eur J Radiol; 2017 Apr; 89():226-233. PubMed ID: 28267544
[TBL] [Abstract][Full Text] [Related]
2. Nonpalpable BI-RADS 4 breast lesions: sonographic findings and pathology correlation.
Elverici E; Barça AN; Aktaş H; Özsoy A; Zengin B; Çavuşoğlu M; Araz L
Diagn Interv Radiol; 2015; 21(3):189-94. PubMed ID: 25835079
[TBL] [Abstract][Full Text] [Related]
3. [Ultrasound follow-up of palpable solid, probably benign breast lesions (BI-RADS category III)].
Graf O; Helbich TH; Fuchsjäger MH; Hopf G; Morgun M; Graf C; Mallek R
Rofo; 2004 Sep; 176(9):1251-6. PubMed ID: 15346259
[TBL] [Abstract][Full Text] [Related]
4. Frequency and outcomes of biopsy-proven fibroadenomas recommended for surgical excision.
Lee S; Mercado CL; Cangiarella JF; Chhor CM
Clin Imaging; 2018; 50():31-36. PubMed ID: 29258029
[TBL] [Abstract][Full Text] [Related]
5. Breast Imaging-Reporting and Data System (BI-RADS) classification in 51 excised palpable pediatric breast masses.
Koning JL; Davenport KP; Poole PS; Kruk PG; Grabowski JE
J Pediatr Surg; 2015 Oct; 50(10):1746-50. PubMed ID: 25783351
[TBL] [Abstract][Full Text] [Related]
6. Automated breast ultrasound: lesion detection and BI-RADS classification--a pilot study.
Wenkel E; Heckmann M; Heinrich M; Schwab SA; Uder M; Schulz-Wendtland R; Bautz WA; Janka R
Rofo; 2008 Sep; 180(9):804-8. PubMed ID: 18704878
[TBL] [Abstract][Full Text] [Related]
7. Patient compliance and diagnostic yield of 18-month unilateral follow-up in surveillance of probably benign mammographic lesions.
Chung CS; Giess CS; Gombos EC; Frost EP; Yeh ED; Raza S; Birdwell RL
AJR Am J Roentgenol; 2014 Apr; 202(4):922-7. PubMed ID: 24660725
[TBL] [Abstract][Full Text] [Related]
8. Reassessment and Follow-Up Results of BI-RADS Category 3 Lesions Detected on Screening Breast Ultrasound.
Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
AJR Am J Roentgenol; 2016 Mar; 206(3):666-72. PubMed ID: 26901026
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of probably benign (BI-RADS 3) lesions in mammography: what is the right follow-up protocol?
Buch KA; Qureshi MM; Carpentier B; Cunningham DA; Stone M; Jaffe C; Quinn M; Gonzalez C; LaVoye J; Hines N; Bloch BN
Breast J; 2015; 21(2):168-74. PubMed ID: 25669425
[TBL] [Abstract][Full Text] [Related]
10. The differences of phyllodes and acoustic attenuation in breast lesions diagnosed with Breast Imaging-Reporting and Data System for Ultrasonography (BI-RADS-US) category 4C.
Li YY; Liu C; Geng J; Li JG; Jin F; Wang XM
Eur J Gynaecol Oncol; 2015; 36(3):294-7. PubMed ID: 26189256
[TBL] [Abstract][Full Text] [Related]
11. Influence of age on PPV of sonographic BI-RADS categories 3, 4, and 5.
Fu CY; Hsu HH; Yu JC; Hsu GC; Hsu KF; Chan DC; Ku CH; Lu TC; Chu CH
Ultraschall Med; 2011 Jan; 32 Suppl 1():S8-13. PubMed ID: 20603785
[TBL] [Abstract][Full Text] [Related]
12. Ultrasonography and core needle biopsy in the differential diagnosis of fibroadenoma and tumor phyllodes.
Bode MK; Rissanen T; Apaja-Sarkkinen M
Acta Radiol; 2007 Sep; 48(7):708-13. PubMed ID: 17728999
[TBL] [Abstract][Full Text] [Related]
13. Is a one-year follow-up an efficient method for better management of MRI BI-RADS(®) 3 lesions?
Boisserie-Lacroix M; Ziadé C; Hurtevent-Labrot G; Ferron S; Brouste V; Lippa N
Breast; 2016 Jun; 27():1-7. PubMed ID: 27212693
[TBL] [Abstract][Full Text] [Related]
14. Benign Phyllodes Tumor of the Breast Diagnosed After Ultrasound-Guided Vacuum-Assisted Biopsy: Surgical Excision or Wait-and-Watch?
Ouyang Q; Li S; Tan C; Zeng Y; Zhu L; Song E; Chen K; Su F
Ann Surg Oncol; 2016 Apr; 23(4):1129-34. PubMed ID: 26577125
[TBL] [Abstract][Full Text] [Related]
15. Texture Analysis of Ultrasound Images to Differentiate Simple Fibroadenomas From Complex Fibroadenomas and Benign Phyllodes Tumors.
Basara Akin I; Ozgul H; Simsek K; Altay C; Secil M; Balci P
J Ultrasound Med; 2020 Oct; 39(10):1993-2003. PubMed ID: 32329531
[TBL] [Abstract][Full Text] [Related]
16. Results of Short-Term Follow-Up in BI-RADS 3 and 4a Breast Lesions with a Histological Diagnosis of Fibroadenoma at Percutaneous Needle Biopsy.
Clauser P; Bazzocchi M; Marcon M; Londero V; Zuiani C
Breast Care (Basel); 2017 Sep; 12(4):238-242. PubMed ID: 29070987
[TBL] [Abstract][Full Text] [Related]
17. Differentiation between phyllodes tumor and fibroadenoma using real-time elastography.
Adamietz BR; Kahmann L; Fasching PA; Schulz-Wendtland R; Uder M; Beckmann MW; Meier-Meitinger M
Ultraschall Med; 2011 Dec; 32 Suppl 2():E75-9. PubMed ID: 22194044
[TBL] [Abstract][Full Text] [Related]
18. BI-RADS 3, 4, and 5 lesions: value of US in management--follow-up and outcome.
Raza S; Chikarmane SA; Neilsen SS; Zorn LM; Birdwell RL
Radiology; 2008 Sep; 248(3):773-81. PubMed ID: 18647850
[TBL] [Abstract][Full Text] [Related]
19. Fibroepithelial Lesions (FELs) of the Breast: Is Routine Excision Always Necessary?
Limberg J; Barker K; Hoda S; Simmons R; Michaels A; Marti JL
World J Surg; 2020 May; 44(5):1552-1558. PubMed ID: 31974650
[TBL] [Abstract][Full Text] [Related]
20. Shear-wave elastography and greyscale assessment of palpable probably benign masses: is biopsy always required?
Giannotti E; Vinnicombe S; Thomson K; McLean D; Purdie C; Jordan L; Evans A
Br J Radiol; 2016 Jun; 89(1062):20150865. PubMed ID: 27007593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
